Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2023 Feb 6;19(4):273. doi: 10.1038/s41581-023-00686-0

Author Correction: Therapeutic advances in COVID-19

Naoka Murakami 1,2, Robert Hayden 1,2, Thomas Hills 3,4, Hanny Al-Samkari 2,5, Jonathan Casey 6, Lorenzo Del Sorbo 7, Patrick R Lawler 7,8, Meghan E Sise 2,9, David E Leaf 1,2,
PMCID: PMC9901371  PMID: 36747084

Correction to: Nature Reviews Nephrology 10.1038/s41581-022-00642-4. Published online 17 October 2022.

In the originally published version of this article, the findings of a cited reference were incorrectly reported. The description has been corrected to read “Similarly, in non-hospitalized unvaccinated older adults with mild COVID-19 symptoms, a double-blind RCT of convalescent plasma versus placebo administered within 72 hours of symptom onset reduced the progression of COVID-19 (ref. 104)” (Libster, R. et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N. Engl. J. Med. 384, 610–618 (2021)). The error has been corrected in the HTML and PDF versions of the article.


Articles from Nature Reviews. Nephrology are provided here courtesy of Nature Publishing Group

RESOURCES